bioMerieux : Overall improvement in H1 2020 - Buy vs Neutral - target price raised to € 96
>BioFire set for a positive flu season? - The various supervisory bodies for flu (ECDC and CDC) have provided interesting signals recently, particularly in the US (80% of FilmArray® sales) for BioFire with its sales set, particularly in Q1 2020, to benefit from favourable comps. Growth at FilmArray® is set to remain at around 25%. The main growth driver for the group continues to offer huge growth potential: new clients, new panels, ramp-up of new countries (e.g....Co. specializes in the field of in vitro diagnostics for clinical and industrial applications. Co. designs, develops, manufactures and markets systems used in: Clinical Applications (the diagnosis of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory illnesses, as well as pathologies such as cardiovascular diseases and cancers, based on the analysis of biological samples such as blood, saliva or urine); and Industrial Applications (microbiological analysis of samples of finished or semi-finished products (or of the environment), chiefly in the food processing and biopharmaceutical industries), detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.